What is the role of the gamma-hydroxybutyrate receptor?

Medical Hypotheses

Volumn 47, Issue 6, 1996, Pages 455-459

  Cash, C D ^a  

^a CENTRE DE NEUROCHIMIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; CANNABINOID RECEPTOR; DRUG RECEPTOR; FREE RADICAL; GUANOSINE TRIPHOSPHATE; MELATONIN;

BINDING SITE; BRAIN TISSUE; HUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; SLEEP; SOLUBILIZATION;

CANNABIS;

EID: 0029801015     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90157-7     Document Type: Article

References (41)

1. Bessman S P, Fishbein W N. Gamma-hydroxybutyrate, a normal brain metabolite. Nature 1963; 4912: 1207-1208.
2. Nelson T, Kaufman E, Kline J, Sokoloff L. The extraneural distribution of γ-hydroxybutyrate. J Neurochem 1981; 37: 1345-1349.
3. Cash C D, Maitre M, Mandel P. Purification from human brain and some properties of two NADPH-linked aldehyde reductases which reduce succinic semialdehyde to 4-hydroxybutyric acid. J Neurochem 1979; 33: 1169-1175.
4. Barker S A, Snead O C, Poldrugo F, Liu C C, Fish F P, Settine R L. Identification and quantification of 1,4-butanediol in mammalian tissues: an alternative biosynthetic pathway for gamma-hydroxybutyric acid. Biochem Pharmacol 1985; 34: 1849-1852.
5. +-linked alcohol oxido-reductase which catalyses the interconversion of γ-hydroxybutyrate and succinic semialdehyde. J Neurochem 1979; 32: 699-712.
6. Kaufman E E, Nelson T, Miller D, Stadlan N. Oxidation of γ-hydroxybutyrate to succinic semialdehyde by a mitochondrial pyridine nucleotide-independent enzyme. J Neurochem 1988; 51: 1079-1084.
7. Benavides J, Rumigny J F, Bourguignon J J et al. High affinity binding sites for γ-hydroxybutyric acid in rat brain. Life Sci 1982; 30: 953-961.
8. Vayer P, Mandel P, Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 1987; 41: 1547-1557.
9. Cash C D. Gammahydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 1994; 18: 291-304.
10. Cardinali D P, Vacas M I, Boyer E E. Specific binding of melatonin in bovine brain. Edocrinology 1979; 105: 437-441.
11. Reiter R J, Tan D X, Poeggeler B, Menendez-Pelaez A, Chen L D, Saarela S. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann NY Acad Sci 1994; 719: 1-12.
12. Pierrefiche G, Laborit H. Oxygen free radicals, melatonin and aging. Exp Gerontol 1995; 30: 213-227.
13. Repert S M, Weaver D R. Melatonin madness. Cell 1995; 83: 1059-1062.
14. Reimund E. The free radical flux theory of sleep. Med Hypotheses 1994; 43: 231-233.
15. Lavyne M H, Robert M D, Hariri J, Tankosic T, Babiak T. Effect of low dose γ-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained, awake rat. Neurosurgery 1983; 12: 430-434.
16. Pierrefiche G, Topall G, Henriet I, Laborit H. Protective effects of gammahydroxybutyrate on alloxan induced diabetes in mice. Res Commun Pathol Pharmacol 1991; 71: 309-319.
17. Colado M I, Green A R. A study of the mechanism of MDMA ('Ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocipline and other protective compounds. Br J Pharmacol 1994; 111: 131-136.
18. Snead O C, Liu C C. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol 1984; 33: 2587-2590.
19. Hechler V, Peter P, Gorbaille S et al. γ-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities. J Pharmacol Exp Ther 1993; 264: 1406-1414.
20. 3H]γ-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not other antipsychotics. Eur J Pharmacol 1994; 256: 211-214.
21. Hechler V, Mersel M, Dreyfus H, Maitre M. Effects of phospholipases, proteases and neuraminindase on γ-hydroxybutyrate binding sites. Mol Cell Biochem 1990; 93: 87-94.
22. Diaz R S, Regueiro P, Monreal J, Tandler C J. Selective extraction, solubilization, and reversed-phase high-performance liquid chromatography separation of the main proteins from myelin using tetrahydrofuran/water mixtures. J Neurosci Res 1991; 29: 114-120.
23. Morgenoth V M, Walters J R, Roth R H. Dopaminergic neurone - alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow. Biochem Pharmacol 1976; 25: 655-661.
24. 9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synapto-somes. J Pharmacol Expt Ther 1982; 221: 97-103.
25. 9-tetrahydrocannabinol in rats and Rhesus monkeys. J Pharmacol Exp Ther 1995; 275: 1-6.
26. Columbo G, Agabio R, Bourguignon J et al. Blockade of the discriminative stimulus effects of γ-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382. Physiol Behav 1995; 58: 587-590.
27. Devane W A, Hanus L, Breuer A et al. Isolation and structure of a brain constituent that binds to the cannabis receptor. Science 1992; 258: 1946-1949.
28. Gallimberti L, Cibin M, Pagnin P et al. Gamma-hydroxybutyrate for the treatment of opiate withdrawal symptoms. Neuropsychopharmacology 1993; 9: 77-82.
29. Vela G, Ruiz-Gayo M, Fuentes J A. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. Neuropharmacology 1995; 34: 665-668.
30. Hechler V, Gobaille S, Maitre M. Selective distribution of γ-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res 1992; 572: 345-348.
31. Herkenham M, Lynn A B, Johnson M R, Melvin L S, de Costa B R, Rice K C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991; 11: 563-583.
32. Munro S, Thomas K L, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61-65.
33. Ratomponirina C, Hodé Y, Hechler V, Maitre M. γ-Hydroxybutyrate receptor binding in rat brain is inhibited by guanyl nucleotides and pertussis toxin. Neurosci Lett 1995; 189: 51-53.
34. Devane W A, Dysarz F A, Johnson M R, Melvin L S, Howlett A C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988; 34: 605-613.
35. Diana M, Mereu G, Mura A, Fadda F, Passino N, Gessa G. Low doses of γ-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res 1991; 566: 208-211.
36. 9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes. J Pharmacol Exp Ther 1982; 221: 97-103.
37. Snead O C, Bearden L J. Naloxone overcomes the dopaminergic, EEG, and behavioral effects of γ-hydroxybutyrate. Neurology 1980; 30: 832-838.
38. 9-Tetretrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of concious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 1990; 102: 156-162.
39. Cravatt B F, Propero-Garcia O, Siuzdak G et al. Chemical characterization of a family of brain lipids that induce sleep. Science 1995; 268: 1506-1509.
40. Matsuda L A, Lolait S J, Browstein M J, Bonner T I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561-564.
41. Fukawa E, Tanaka H, Makino I. Identification and characterization of guanine nucleotide-sensitive melatonin receptors in chicken brain. Neuropharmacology 1995: 34: 767-776.